Pancreatic Ductal Adenocarcinoma Concomitant with Intraductal Papillary Mucinous Neoplasm: a Report of 8 Cases
Overview
Authors
Affiliations
Branch-duct intraductal papillary mucinous neoplasm (BD-IPMN) is recognized as a risk factor for pancreatic ductal adenocarcinoma (PDAC) that is unrelated to the malignant transformation of IPMN. We experienced 8 cases of resected PDAC concomitant with IPMN from March 1988 to December 2012, and 7 patients had >2 risk factors, including IPMN, for pancreatic cancer. Seven of the IPMNs were <30 mm in size, while none had mural nodules. Four cases of PDAC were detected during the follow-up period for BD-IPMN. Neither magnetic resonance cholangiopancreaticography nor contrast-enhanced computed tomography performed 5 months prior to the detection of PDAC resulted in its early detection in 2 cases. The clinical features of the 8 cases indicate that particular attention is required for patients with >1 risk factor, in addition to IPMN, for pancreatic cancer. A shorter interval of surveillance than that suggested by the international consensus guidelines 2012 is required, even if the IPMNs are small, for the early detection of PDAC.
Kanemitsu E, Masui T, Nagai K, Anazawa T, Kasai Y, Yogo A Ann Surg Oncol. 2023; 30(7):4392-4406.
PMID: 36933081 DOI: 10.1245/s10434-023-13309-6.
Yonamine K, Koshita S, Kanno Y, Ogawa T, Kusunose H, Sakai T Am J Case Rep. 2021; 22:e932565.
PMID: 34473678 PMC: 8422565. DOI: 10.12659/AJCR.932565.
Takigawa Y, Kitago M, Matsui J Surg Today. 2020; 50(12):1672-1680.
PMID: 32661567 PMC: 7677271. DOI: 10.1007/s00595-020-02074-8.